Harila-Saari AH - Search Results

1

Brain perfusion after treatment of childhood acute lymphoblastic leukemia.

Harila-Saari AH, Ahonen AK, Vainionpää LK, Pääkkö EL, Pyhtinen J, Himanen AS, Torniainen PJ, Lanning BM. Harila-Saari AH, et al. J Nucl Med. 1997 Jan;38(1):82-8. J Nucl Med. 1997. PMID: 8998157 Free article.

2

Nerve lesions after therapy for childhood acute lymphoblastic leukemia.

Harila-Saari AH, Vainionpää LK, Kovala TT, Tolonen EU, Lanning BM. Harila-Saari AH, et al. Cancer. 1998 Jan 1;82(1):200-7. doi: 10.1002/(sici)1097-0142(19980101)82:1<200::aid-cncr25>3.0.co;2-5. Cancer. 1998. PMID: 9428498

3

Bone marrow changes on MRI in children with acute lymphoblastic leukaemia 5 years after treatment.

Ojala AE, Pääkkö E, Lanning FP, Harila-Saari AH, Lanning BM. Ojala AE, et al. Clin Radiol. 1998 Feb;53(2):131-6. doi: 10.1016/s0009-9260(98)80060-3. Clin Radiol. 1998. PMID: 9502090

4

A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia.

Harila-Saari AH, Pääkkö EL, Vainionpää LK, Pyhtinen J, Lanning BM. Harila-Saari AH, et al. Cancer. 1998 Dec 15;83(12):2608-17. Cancer. 1998. PMID: 9874469

5

Cerebral blood flow and glucose metabolism in long-term survivors of childhood acute lymphoblastic leukaemia.

Kähkönen M, Harila-Saari A, Metsähonkala L, Korhonen T, Norvasuo-Heilä MK, Utriainen T, Ahonen A, Bergman J, Salmi TT, Minn H. Kähkönen M, et al. Eur J Cancer. 1999 Jul;35(7):1102-8. doi: 10.1016/s0959-8049(99)00053-2. Eur J Cancer. 1999. PMID: 10533455

6

Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.

Kähkönen M, Metsähonkala L, Minn H, Utriainen T, Korhonen T, Norvasuo-Heilä MK, Harila-Saari A, Aärimaa T, Suhonen-Polvi H, Ruotsalainen U, Solin O, Salmi TT. Kähkönen M, et al. Cancer. 2000 Feb 1;88(3):693-700. Cancer. 2000. PMID: 10649265

7

White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.

Pääkkö E, Harila-Saari A, Vanionpää L, Himanen S, Pyhtinen J, Lanning M. Pääkkö E, et al. Med Pediatr Oncol. 2000 Nov;35(5):456-61. doi: 10.1002/1096-911x(20001101)35:5<456::aid-mpo3>3.0.co;2-1. Med Pediatr Oncol. 2000. PMID: 11070477

8

Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.

Harila-Saari AH, Huuskonen UE, Tolonen U, Vainionpää LK, Lanning BM. Harila-Saari AH, et al. Med Pediatr Oncol. 2001 Mar;36(3):345-51. doi: 10.1002/mpo.1084. Med Pediatr Oncol. 2001. PMID: 11241435

9

Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia.

Lehtinen SS, Huuskonen UE, Harila-Saari AH, Tolonen U, Vainionpää LK, Lanning BM. Lehtinen SS, et al. Cancer. 2002 May 1;94(9):2466-73. doi: 10.1002/cncr.10503. Cancer. 2002. PMID: 12015772 Free article.

10

Perfusion MRI and SPECT of brain after treatment for childhood acute lymphoblastic leukemia.

Pääkkö E, Lehtinen S, Harila-Saari A, Ahonen A, Jauhiainen J, Torniainen P, Pyhtinen J, Lanning M. Pääkkö E, et al. Med Pediatr Oncol. 2003 Feb;40(2):88-92. doi: 10.1002/mpo.10210. Med Pediatr Oncol. 2003. PMID: 12461791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters